Smofkabiven Peripheral 18 mg

SMOFKABIVEN Peripheral 18 mg is an intravenous emulsion containing calcium chloride, designed for nutritional support. This product is manufactured by Fresenius Kabi Canada Ltd. and is suitable for peripheral administration.

SMOFKABIVEN Peripheral 18 mg is primarily used for nutritional support in patients who require intravenous feeding. It provides essential nutrients, including calcium, which is crucial for various bodily functions. This emulsion is often used in clinical settings where oral nutrition is not feasible or sufficient. What is SMOFKABIVEN Peripheral 18 mg used for? It is typically used to support patients who need nutritional supplementation through intravenous means.

Common effects of SMOFKABIVEN Peripheral 18 mg may include improved nutritional status and support for patients who cannot consume food orally. The emulsion is designed to be well-tolerated when administered intravenously. However, individual responses can vary, and it is important to monitor patients for any adverse reactions.

SMOFKABIVEN Peripheral 18 mg should be handled with care to ensure sterility and proper administration. It is important to follow the manufacturer's guidelines for storage and usage. Patients with known allergies to any of the components should avoid using this product. Always consult a healthcare professional before starting any new nutritional support regimen.

SMOFKABIVEN Peripheral 18 mg may interact with other medications or supplements, particularly those that affect calcium levels in the body. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, caution should be exercised when using this product with other intravenous treatments.